RAPT Therapeutics, Inc. RAPT
Set alert
58.01 USD 0.00 0.00%
As of Mar 6, 9:30 AM ET
58.01 Day range 58.01
26.50 52-week range 58.02
- YTD
- +71.26%
- 1 year
- +547.38%
- Open
- 58.01
- Prev close
- 58.01
- Mkt cap
- 1.61B
- Vol
- 10.85M
- Avg vol
- 4.25M
- EPS
- -11.06
- P/E
- -44.46
- Div yield
- 0.00%
More statistics
- Low
- 58.01
- High
- 58.01
- Beta
- 0.44
- Inst. own
- 110.57%
- Dividend
- 0.00
Financial health
Altman Z-Score
63.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -4.0×
FY 2017 5y median -65.3× FY 2024
P/S 0.0×
FY 2017 5y median 756× FY 2024
P/B 2.7×
FY 2017 5y median 36.6× FY 2024
P/FCF -6.2×
FY 2017 5y median -77.6× FY 2024
EV/EBITDA -2.7×
FY 2017 5y median -65.6× FY 2024
EV/Sales 0.0×
FY 2017 5y median 751× FY 2024
FCF Yield -16.2%
FY 2017 5y median -1.3% FY 2024
Profitability
Gross Margin 0.0%
FY 2017 5y median 100.0% FY 2024
Operating Margin 0.0%
FY 2017 5y median -1055.4% FY 2024
Net Margin 0.0%
FY 2017 5y median -1049.0% FY 2024
ROE -68.4%
FY 2017 5y median -50.8% FY 2024
ROIC -70.0%
FY 2017 5y median -49.6% FY 2024
ROA -54.0%
FY 2017 5y median -44.5% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2024
Operating Income -7.1%
FY 2017 FY 2024
EPS (diluted) -4.6%
FY 2017 FY 2024
Free Cash Flow 15.0%
FY 2017 FY 2024
Financial Health
Current Ratio 4.9×
FY 2017 5y median 9.8× FY 2024
Quick Ratio 4.9×
FY 2017 5y median 9.8× FY 2024
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2024
Net Debt / EBITDA 1.3×
FY 2017 5y median 0.4× FY 2024
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2024
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31